BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Avalon Pharmaceuticals 

20358 Seneca Meadows Parkway

Germantown  Maryland  20876  U.S.A.
Phone: 301-556-9900 Fax: 301-556-9910


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Genomics

Collaborations

MedImmune 





 Company News
Intrexon Corporation (JOBS) Announces Purchase of Industry-Leading Bioassay Operation from Avalon Pharmaceuticals (AVRX) 9/1/2009 7:10:51 AM
Clinical Data Completes Acquisition of Avalon Pharmaceuticals (AVRX) 5/29/2009 8:53:06 AM
Avalon Pharmaceuticals (AVRX) Announces Special Meeting Date 4/29/2009 10:24:53 AM
Avalon Pharmaceuticals (AVRX) Receives Audit Opinion Containing Going Concern Statement 4/7/2009 1:34:51 PM
Avalon Pharmaceuticals (AVRX) Receives Extension of Time to Comply with NASDAQ Deficiency Notice 12/23/2008 8:20:54 AM
Avalon Pharmaceuticals (AVRX) Receives NASDAQ Deficiency Notice 11/25/2008 1:01:28 PM
Clinical Data to Acquire Avalon Pharmaceuticals (AVRX) for $10 Million; Expands Development Capabilities in Targeted Therapeutics and Molecular Diagnostics for Oncology 10/28/2008 10:22:45 AM
Avalon Pharmaceuticals (AVRX) Receives Nasdaq Deficiency Notice 9/29/2008 9:01:54 AM
Avalon Pharmaceuticals (AVRX) Reports Second Quarter 2008 Results 8/13/2008 8:31:45 AM
Avalon Pharmaceuticals (AVRX) Sets Second Quarter 2008 Conference Call Date 8/5/2008 8:38:14 AM
12345678910...